Logo image of SINT

SINTX TECHNOLOGIES INC (SINT) Stock Price, Forecast & Analysis

USA - NASDAQ:SINT - US8293927039 - Common Stock

3.49 USD
+0.34 (+10.79%)
Last: 11/17/2025, 8:19:04 PM
3.44 USD
-0.05 (-1.43%)
After Hours: 11/17/2025, 8:19:04 PM

SINT Key Statistics, Chart & Performance

Key Statistics
Market Cap12.53M
Revenue(TTM)2.89M
Net Income(TTM)-12.54M
Shares3.59M
Float3.06M
52 Week High8.6
52 Week Low1.71
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-6.8
PEN/A
Fwd PEN/A
Earnings (Next)03-17 2026-03-17
IPO2014-02-11
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


SINT short term performance overview.The bars show the price performance of SINT in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 20

SINT long term performance overview.The bars show the price performance of SINT in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of SINT is 3.49 USD. In the past month the price increased by 4.18%. In the past year, price decreased by -29.64%.

SINTX TECHNOLOGIES INC / SINT Daily stock chart

SINT Latest News, Press Relases and Analysis

SINT Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 26.06 226.31B
ISRG INTUITIVE SURGICAL INC 63.5 195.98B
BSX BOSTON SCIENTIFIC CORP 34.49 150.78B
SYK STRYKER CORP 27.34 137.68B
BDX BECTON DICKINSON AND CO 13.24 54.74B
IDXX IDEXX LABORATORIES INC 53.05 53.52B
EW EDWARDS LIFESCIENCES CORP 32.97 49.75B
RMD RESMED INC 24.72 35.71B
GEHC GE HEALTHCARE TECHNOLOGY 15.39 32.25B
PODD INSULET CORP 71.78 23.09B
DXCM DEXCOM INC 31.45 22.94B
ZBH ZIMMER BIOMET HOLDINGS INC 10.96 17.56B

About SINT

Company Profile

SINT logo image SINTX Technologies, Inc. is a ceramics company, which engages in the development and commercialization of silicon nitride for medical and non-medical applications. The company is headquartered in Salt Lake City, Utah and currently employs 20 full-time employees. The company went IPO on 2014-02-11. The company is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. The company has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. The company manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.

Company Info

SINTX TECHNOLOGIES INC

1885 West 2100 Street

Salt Lake City UTAH 84119 US

CEO: B. Sonny Bal

Employees: 20

SINT Company Website

SINT Investor Relations

Phone: 18018393516

SINTX TECHNOLOGIES INC / SINT FAQ

Can you describe the business of SINTX TECHNOLOGIES INC?

SINTX Technologies, Inc. is a ceramics company, which engages in the development and commercialization of silicon nitride for medical and non-medical applications. The company is headquartered in Salt Lake City, Utah and currently employs 20 full-time employees. The company went IPO on 2014-02-11. The company is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. The company has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. The company manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.


What is the current price of SINT stock?

The current stock price of SINT is 3.49 USD. The price increased by 10.79% in the last trading session.


Does SINT stock pay dividends?

SINT does not pay a dividend.


What is the ChartMill rating of SINTX TECHNOLOGIES INC stock?

SINT has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


How is the valuation of SINTX TECHNOLOGIES INC (SINT) based on its PE ratio?

SINTX TECHNOLOGIES INC (SINT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-6.8).


Can you provide the market cap for SINTX TECHNOLOGIES INC?

SINTX TECHNOLOGIES INC (SINT) has a market capitalization of 12.53M USD. This makes SINT a Nano Cap stock.


Can you provide the upcoming earnings date for SINTX TECHNOLOGIES INC?

SINTX TECHNOLOGIES INC (SINT) will report earnings on 2026-03-17.


SINT Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to SINT. When comparing the yearly performance of all stocks, SINT is a bad performer in the overall market: 77.84% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

SINT Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to SINT. While SINT seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SINT Financial Highlights

Over the last trailing twelve months SINT reported a non-GAAP Earnings per Share(EPS) of -6.8. The EPS increased by 92.7% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -136.42%
ROE -314.54%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-126.14%
Sales Q2Q%-73.97%
EPS 1Y (TTM)92.7%
Revenue 1Y (TTM)9.9%

SINT Forecast & Estimates

7 analysts have analysed SINT and the average price target is 25.5 USD. This implies a price increase of 630.66% is expected in the next year compared to the current price of 3.49.

For the next year, analysts expect an EPS growth of 82.02% and a revenue growth -67.16% for SINT


Analysts
Analysts82.86
Price Target25.5 (630.66%)
EPS Next Y82.02%
Revenue Next Year-67.16%

SINT Ownership

Ownership
Inst Owners5.93%
Ins Owners8.6%
Short Float %3.52%
Short Ratio0.1